Skip to main content

pancreatic cancer Archives

Patient undergoes novel therapy to treat pancreatic cancer

Feb. 16, 2023—Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.

Read more


Vanderbilt lauded for pancreatic cancer, pancreatitis care

Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

Read more


Nerve cells and cancer progression

Sep. 22, 2022—Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

Read more


Pancreatic cancer clue

Aug. 12, 2019—Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

Read more


Clinical study tests drug that may prevent cancer metastasis

Jul. 8, 2019—A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Read more


Searching out pancreatic cancer risk

Dec. 7, 2017—Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.

Read more


Pancreatic cancer development

Aug. 31, 2017—Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.

Read more


Metastatic pancreatic cancer ‘reprograms’ for malignancy

Jan. 19, 2017—Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics.

Read more


Chemo better option following pancreatic cancer surgery: study

Feb. 25, 2016—A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.

Read more


Grant bolsters pancreatic cancer drug discovery efforts

Jan. 29, 2015—The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

Read more


Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Jan. 9, 2014—Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.

Read more


Study helps define pancreatic cancer’s cellular origins

Jan. 17, 2013—Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more